News Sentiment

ELAN sentiment intelligence

Elanco Animal Health news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 58 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 24.82 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-0.7% over one week, +2.7% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?

Market Reaction

Balanced read

54/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -0.7% Price digesting
Trend fit Trend inactive 2.7% over four weeks
Fair value 54.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 39
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 17
Market source 8
simplywall.st 6
TradingView 5
MarketBeat 4
Investing.com Canada 2
MT Newswires 2
CSRwire 1

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 13
Balance sheet 6
Analyst action 4
Regulatory and legal 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 58
Stock Titan Direct company coverage

Elanco Animal Health (NYSE: ELAN) awards deferred stock units to company officer

Elanco Animal Health (NYSE: ELAN) officer Rajeev A. Modi was granted 59.5056 deferred stock units on July 10, 2026, valued at $24.82 per unit. These units, which represent the right to one share of common stock or cash equivalent, will settle after employment ends or in a specifi

Tone
Neutral 50/100
Event
Balance sheet
Published
14 Jul 2026 20:15
Source
Stock Titan
Stock Titan Direct company coverage

Elanco Animal Health (NYSE: ELAN) awards CEO new deferred stock units

Elanco Animal Health's CEO, Jeffrey N. Simmons, was granted 113.8973 deferred stock units on July 10, 2026, valued at $24.82 per unit. These units represent a right to receive one share of common stock or its cash equivalent, settling upon employment termination or a specified fu

Tone
Neutral 50/100
Event
Balance sheet
Published
14 Jul 2026 20:15
Source
Stock Titan
Stock Titan Direct company coverage

Elanco Animal Health (NYSE: ELAN) awards CFO new deferred stock units

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, was granted 7.9380 deferred stock units on July 10, 2026, with a reference value of $24.82 per unit. Following this transaction, he holds a total of 116.7886 deferred stock units. These units represent the right to recei

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 20:15
Source
Stock Titan
MarketBeat Direct company coverage

Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Recommendation of "Moderate Buy" by Brokerages

Elanco Animal Health Incorporated (NYSE:ELAN) has received a consensus "Moderate Buy" rating from 13 brokerage firms, with an average 12-month price target of $28.55. Recent analyst adjustments include price target increases from JPMorgan, TD Cowen, and Citigroup, while Weiss Rat

Tone
Positive 68/100
Event
Analyst action
Published
14 Jul 2026 07:10
Source
MarketBeat
CSRwire Direct company coverage

How Elanco Helped Puppies Fight Parvo

Elanco partnered with the Arizona Humane Society to combat rising cases of canine parvovirus. Through this collaboration, the shelter utilized Elanco's Trutect™ treatment, a monoclonal antibody designed to neutralize the virus, significantly reducing hospital time for infected pu

Tone
Positive 73/100
Event
Market update
Published
13 Jul 2026 15:02
Source
CSRwire
Stock Titan Direct company coverage

Elanco (NYSE: ELAN) CFO uses 15,336 shares to cover tax liability

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, disposed of 15,336 shares of common stock at $24.64 per share. This transaction was a tax-withholding disposition to satisfy tax obligations, not an open-market sale. Following this, VanHimbergen directly holds 133,316 s

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 20:36
Source
Stock Titan
Investing.com Canada Direct company coverage

Form 4 Elanco Animal Health For: 9 July By Investing.com

This article from Investing.com reports on a Form 4 filing for Elanco Animal Health (ELAN) related to July 9th. Form 4s detail changes in beneficial ownership of securities by company insiders, but no specific transaction details are provided in this brief announcement. The artic

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 20:36
Source
Investing.com Canada
TradingView Direct company coverage

Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement

Elanco Animal Health Incorporated (ELAN) announced it will release its second quarter 2026 financial results on Wednesday, August 5, 2026. The company will also host a conference call for the investment community and media at 8:00 a.m. eastern time on the same day. A live webcast

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 14:40
Source
TradingView
Stock Titan Direct company coverage

Elanco sets Aug. 5 call for second-quarter 2026 results

Elanco Animal Health Incorporated (NYSE: ELAN) will release its second-quarter 2026 financial results on Wednesday, August 5, 2026. A conference call for investors, media, and the public will be held the same day at 8:00 a.m. Eastern Time, with a live webcast and replay available

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 11:39
Source
Stock Titan
MarketBeat Direct company coverage

Integrated Advisors Network LLC Purchases New Position in Elanco Animal Health Incorporated $ELAN

Integrated Advisors Network LLC initiated a new position in Elanco Animal Health (NYSE:ELAN) during the first quarter, acquiring 264,076 shares valued at approximately $6.3 million. The institutional ownership of Elanco remains high at 97.48%, with several other funds recently in

Tone
Positive 65/100
Event
Earnings
Published
07 Jul 2026 16:10
Source
MarketBeat
MarketBeat Direct company coverage

Strs Ohio Grows Position in Elanco Animal Health Incorporated $ELAN

Strs Ohio significantly increased its stake in Elanco Animal Health (NYSE:ELAN) during the first quarter of 2026, boosting its holdings by 848.2% to 111,770 shares valued at $2.68 million. This increase follows Elanco's better-than-expected Q1 results, with earnings and revenue s

Tone
Positive 67/100
Event
Earnings
Published
07 Jul 2026 14:10
Source
MarketBeat
MarketBeat Direct company coverage

SG Americas Securities LLC Reduces Stock Position in Elanco Animal Health Incorporated $ELAN

SG Americas Securities LLC significantly reduced its stake in Elanco Animal Health (NYSE: ELAN) by 65.1% in the first quarter, selling 62,227 shares. Despite this reduction, Elanco reported stronger-than-expected quarterly results, with EPS of $0.40 and revenue of $1.37 billion,

Tone
Positive 66/100
Event
Earnings
Published
06 Jul 2026 08:41
Source
MarketBeat
GuruFocus Direct company coverage

NYSE: ELAN Lawsuit Alert: Investors who lost money with Elanco A

The Shareholders Foundation announced that a lawsuit is pending against Elanco Animal Health Incorporated (NYSE: ELAN) for alleged securities law violations. The lawsuit claims Elanco made false or misleading statements regarding the safety of Zenrelia and the approval timelines

Tone
Negative 20/100
Event
Regulatory and legal
Published
04 Jul 2026 14:12
Source
GuruFocus
Investing.com Nigeria Direct company coverage

Form 4 Elanco Animal Health For: 2 July By Investing.com

This article is a brief announcement from Investing.com about the filing of Form 4 for Elanco Animal Health on July 2nd. It provides no further details beyond stating the company and the date of the filing. The article appears to be an automated notification of a regulatory filin

Tone
Neutral 50/100
Event
Regulatory and legal
Published
03 Jul 2026 13:41
Source
Investing.com Nigeria
TradingView Direct company coverage

ETFs Investing in Elanco Animal Health, Inc. Stocks

The article lists numerous ETFs that hold Elanco Animal Health, Inc. stock, providing details such as market value, weight in the fund, issuer, management style, expense ratio, assets under management (AUM), and 3-year NAV total return. This information is intended to help invest

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 03:11
Source
TradingView
Stock Titan Direct company coverage

Elanco (ELAN) executive awarded 25,620 stock options at $24.09 strike price

David S. Kinard, an executive at Elanco Animal Health Inc. (ELAN), was granted 25,620 employee stock options with an exercise price of $24.09 per share. These options will vest in three equal annual installments beginning March 1, 2027, and will expire on July 1, 2036. Following

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 21:11
Source
Stock Titan
Stock Titan Direct company coverage

Elanco (ELAN) director converts cash fees into 584 deferred stock units

Elanco Animal Health director K. Anand converted her cash director retainer fees into 584.1121 Deferred Stock Units (DSUs) on June 30, 2026, at an implied price of $24.61 per unit. These DSUs are economically equivalent to common stock shares and will be settled in stock upon her

Tone
Neutral 50/100
Event
Balance sheet
Published
02 Jul 2026 21:11
Source
Stock Titan
Stock Titan Direct company coverage

Elanco (NYSE: ELAN) CFO gets new deferred stock unit award

Elanco Animal Health's EVP and CFO, Robert M. VanHimbergen, received a grant of 8.0187 deferred stock units, increasing his total holdings to 108.8506 units. These units, valued at $24.57 each, represent a right to receive company common stock or its cash equivalent upon terminat

Tone
Neutral 50/100
Event
Balance sheet
Published
01 Jul 2026 12:09
Source
Stock Titan
TradingView Direct company coverage

Is the Options Market Predicting a Spike in Elanco Animal Health Stock?

The article explores whether the options market is signaling a significant move for Elanco Animal Health (ELAN) stock, noting the high implied volatility in a specific call option. It explains that high implied volatility often precedes large stock movements due to anticipated ev

Tone
Negative 41/100
Event
Market update
Published
01 Jul 2026 00:40
Source
TradingView
Stock Titan Direct company coverage

Elanco (ELAN) CEO Jeffrey Simmons receives 115 deferred stock units grant

Elanco Animal Health Inc. CEO Jeffrey N. Simmons was granted 115.0562 deferred stock units, each valued at $24.57. This compensation-related award increases his total holdings to 24,657.0048 deferred stock units. These units will settle in cash or company shares upon the terminat

Tone
Neutral 50/100
Event
Balance sheet
Published
30 Jun 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Elanco (NYSE: ELAN) executive receives new deferred stock unit award

Elanco executive Rajeev A. Modi has been granted 60.1111 deferred stock units (DSUs) at a reference price of $24.57 per unit, bringing his total DSU holdings to 9,523.1312. These DSUs represent the right to receive Elanco common stock or cash equivalent, and will settle after emp

Tone
Neutral 50/100
Event
Balance sheet
Published
30 Jun 2026 20:10
Source
Stock Titan
InkFreeNews.com Direct company coverage

Elanco Commits To Supporting US In Fight Against Screwworm

Elanco Animal Health has reaffirmed its commitment to combating the New World screwworm threat in the US, following the first confirmed case in Texas. The company states it will provide resources and treatment options for veterinarians, livestock producers, and pet owners. Elanco

Tone
Positive 71/100
Event
Market update
Published
30 Jun 2026 19:10
Source
InkFreeNews.com
TradingView Direct company coverage

Enterprise value to EBIT forward of Elanco Animal Health Incorporated – NYSE:ELAN

This article provides financial information for Elanco Animal Health Incorporated (NYSE:ELAN), specifically focusing on its enterprise value to EBIT forward ratio. The content appears to be a stub or a section of a larger financial data display from TradingView, indicating a plac

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 05:09
Source
TradingView
TradingView Direct company coverage

Elanco Animal Health, Inc. Actuals & Estimates (NYSE:ELAN)

This article provides an overview of Elanco Animal Health Incorporated (NYSE: ELAN) stock, including its current price, market capitalization, and historical performance. It details financial actuals and analyst estimates for income, revenue, and earnings, highlighting that ELAN

Tone
Positive 66/100
Event
Earnings
Published
29 Jun 2026 15:41
Source
TradingView
Investing.com Canada Direct company coverage

Piper Sandler reiterates Elanco stock rating on defensive positioning By Investing.com

Piper Sandler has reiterated an Overweight rating and a $30.00 price target for Elanco Animal Health due to its defensive positioning in the animal health sector. Despite structural headwinds from declining puppy visits, Elanco is expected to perform better than its peers because

Tone
Positive 72/100
Event
Analyst action
Published
29 Jun 2026 14:41
Source
Investing.com Canada